13-30461422-CTT-C
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PVS1_StrongPM2
The NM_002128.7(HMGB1):c.581_582delAA(p.Glu194GlyfsTer3) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002128.7 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HMGB1 | NM_002128.7 | c.581_582delAA | p.Glu194GlyfsTer3 | frameshift_variant | Exon 5 of 5 | ENST00000341423.10 | NP_002119.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
HMGB1-related Developmental delay and microcephaly Uncertain:1
The de novo heterozygous frameshift variant (p.Glu194GlyfsTer3) identified in HMGB1 has not been reported in affected individuals in the literature. The variant is absent from the gnomAD database (v3) indicating it is an extremely rare allele in the general population. The p.Glu194GlyfsTer3 variant is located in the last exon (5/5) of the HMGB1 gene. The resulting mutant mRNA is predicted to escape nonsense mediated mRNA decay and removes more than 10% of transcript. Frameshift and stop-gained variants downstream of p.Glu194GlyfsTer3 have not been reported in the literature. Based on the available evidence, the de novo Glu194GlyfsTer3 variant identified in HMGB1 is assessed as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.